Frontage Holdings Corporation (FRONTAGE, 01521) has dispatched a circular for its Annual General Meeting (AGM) to be held on 2 Jun 2026 in Shanghai. Key resolutions are:

1. Board composition • Re-election of Executive Director Dr. Song Li and Independent Non-executive Directors Mr. Yifan Li and Mr. Erh Fei Liu. • The Nomination Committee confirms the independence of the two INEDs.

2. Capital management authorities • Share repurchase mandate: Board may buy back up to 10% of issued shares (203.45 million shares) during the mandate period. • General issuance mandate: Board may allot and issue up to 20% of issued shares (406.90 million shares); the mandate may be extended by the amount of shares actually repurchased.

3. Equity incentives • Annual mandate under the 2018 Share Incentive Plan to grant Awards covering up to 85.82 million shares, representing 4.21% of current issued share capital. This does not change the overall scheme cap of 200.76 million shares set at IPO.

4. Auditor re-appointment • Proposal to re-appoint BDO Limited as external auditor for the 2026 financial year with an estimated audit fee of RMB2.40 million.

5. Share capital snapshot (22 Apr 2026) • Issued shares: 2,038.02 million • Shares held in treasury pending cancellation: 3.54 million • Shares entitled to vote: 2,034.49 million

6. Controlling shareholders • Hangzhou Tigermed and Hongkong Tigermed collectively hold 1,314.50 million shares (64.50%). Full exercise of the 10% buy-back mandate would lift their combined stake to approximately 71.67%, still below the mandatory offer threshold.

7. Key timetable • Register closure for AGM: 27 May – 2 Jun 2026 (both dates inclusive). • Proxy deadline: 10:00 a.m., 31 May 2026 (Hong Kong time).

All resolutions will be decided by poll. Completion and return of a proxy form will not preclude shareholders from attending and voting in person.